Drug intelligence / Profile preview

s-nitroso-n-acetylpenicillamine

Development stage
Unknown
Lead developer
Merck KGaA
Modality
Small Molecules
Administration
Topical, Intravenous
01

Overview

S-nitroso-N-acetylpenicillamine (SNAP) is a synthetic S-nitrosothiol that serves as a potent and relatively stable nitric oxide (NO) donor. It is extensively utilized as a pharmacological tool in laboratory research to investigate the biological roles of nitric oxide, particularly its effects on vascular smooth muscle relaxation, inhibition of platelet aggregation, and modulation of inflammation. SNAP releases NO spontaneously under physiological conditions, which subsequently activates soluble guanylyl cyclase (sGC), leading to an increase in intracellular cyclic guanosine monophosphate (cGMP). In experimental models of sepsis, SNAP has been shown to rescue impaired capillary blood flow, highlighting its potential to counteract microvascular dysfunction. It is primarily available as a research reagent and is not currently approved for clinical use in humans.

Other names
S-Nitroso-N-acetyl-DL-penicillamineS-Nitroso-N-acetyl-D-penicillamine
02

Targets

sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on s-nitroso-n-acetylpenicillamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on s-nitroso-n-acetylpenicillamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call